Overview

Chronic Reduction of Fasting Glycaemia With Insulin Glargine Improves First and Second Phase Insulin Secretion in Patients With Type 2 Diabetes

Status:
Completed

Trial end date:
2010-05-01

Target enrollment:

Participant gender:

Summary

Glucose-induced insulin secretion is often diminished in hyperglycaemic patients with type 2 diabetes. The investigators examined, whether chronic basal insulin treatment with insulin glargine lead to improvements in glucose-induced insulin secretion.

Phase:

Phase 4

Details

Lead Sponsor:

Ruhr University of Bochum

Treatments:

Insulin
Insulin Glargine
Insulin, Globin Zinc